FDA.reportPublic FDA data

ETHYLCELLULOSE, UNSPECIFIED

Substance profile for UNII 7Z8S9VYZ4B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
7Z8S9VYZ4B
Preferred term
ETHYLCELLULOSE, UNSPECIFIED
Registry number
9004-57-3
Ingredient type
UNSPECIFIED INGREDIENT

Chemical And Database Identifiers#

RxCUI
1310565
PubChem
0
INN ID
7723

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1310565https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1310565
FDA Substance Registration System7Z8S9VYZ4Bhttps://precision.fda.gov/uniisearch/srs/unii/7Z8S9VYZ4B

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BAMOXICILLIN AND CLAVULANATE POTASSIUM1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use amoxicillin and clavulanate potassium safely and effectively. See full prescribing information for amoxicillin and clavulanate potassium. AMOXICILLIN and CLAVULANATE Potassium Tablets, USP and For Oral Suspension USP, for Oral Use Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium and other antibacterial drugs, amoxicillin and clavulanate pot1
EthylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use DURLAZA ™ safely and effectively. See full prescribing information for DURLAZA. DURLAZA (aspirin) Extended Release Capsules, for oral use Initial U.S. Approval:20156
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BOrphenadrine Citrate Extended-Release Tablets1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BBUPROPION HYDROCHLORIDE2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use bupropion hydrochloride extended-release tablets (XL) safely and effectively. See full prescribing information for bupropion hydrochloride extended-release tablets (XL). Bupropion Hydrochloride Extended-Release Tablets, USP (XL) for oral use Initial U.S. Approval: 19853
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BPOTASSIUM CHLORIDE EXTENDED - RELEASE TABLETS, USP1
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BBlistex ® Kank-A ® Liquid1
EthylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BFerretts Iron Supplement1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BAllergy Attack Relief to Go ™4
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BUnknown Title1000
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BPOTASSIUM CHLORIDE EXTENDED - RELEASE TABLETS, USP2
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BHEADACHE RELIEF TO-GO ™1
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BHeadache Relief To Go ™1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use Quetiapine Fumarate Tablets safely and effectively. See full prescribing information for Quetiapine Fumarate Tablets. Quetiapine Fumarate Tablets Initial U.S. Approval: 19972
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BK-TAB® (potassium chloride extended-release tablets, USP)2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1997 budesonide capsules (enteric coated) budesonide capsules (enteric coated) BUDESONIDE capsules (enteric coated), for oral use2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BConRx ® NightTime1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BFexofenadine HCl and Pseudoephedrine HCI ER Tablets USP 180240 mg1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BVenlafaxine Hydrochloride Extended-Release Capsules Rx only3
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BMetadate ® ER Tablets (methylphenidate hydrochloride extended-release tablets, USP) CII9
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BBupropion Hydrochloride Extended-Release Tablets USP (XL)1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BPROPRANOLOL HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use AMOXICILLIN AND CLAVULANATE POTASSIUM, USP safely and effectively. See full prescribing information for AMOXICILLIN AND CLAVULANATE POTASSIUM, USP. Amoxicillin and Clavulanate Potassium Tablets, USP, for Oral Suspension, USP, and Chewable Tablets, USP Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium and other antibacterial drugs, amoxicilli3
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNifedical XL ® (NIFEDIPINE) Tablet, Film Coated Extended Release USP1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNifedical XL ® (NIFEDIPINE) Tablet, Film Coated Extended Release USP1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4Bb733c439-905b-4e8f-8fc0-acde148974c41
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex Sodium Extended-release Tablets, USP for oral use Initial U.S. Approval: 20001
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNifedipine Extended-Release Tablets, USP 30 mg2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral Use INITIAL U.S. APPROVAL: 19925
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-release Capsules, USP INITIAL U.S. APPROVAL: 19891
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BPRESCRIBING INFORMATION BuPROPion Hydrochloride Extended-Release Tablets (XL)3
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BPOTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES, USP, 10 mEq3
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BMETHYLDOPA TABLETS USP Rx only1
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BDelsym 12 Hour Cough Relief Orange1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BDrug facts1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BWELLBUTRIN XL ® (bupropion hydrochloride extended-release tablets)1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNITROGLYCERIN EXTENDED-RELEASE CAPSULES2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNITROGLYCERIN EXTENDED-RELEASE CAPSULES2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use ROPINIROLE extended-release tablets safely and effectively. See full prescribing information for ROPINIROLE extended-release tablets. ROPINIROLE extended-release tablets for oral use Initial U.S. Approval: 19971
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BPotassium Chloride Extended-Release Capsules, USP 8 mEq (600 mg) and 10 mEq (750 mg) Rx Only P10009-1 08/113
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use verapamil hydrochloride extended-release capsules (PM) safely and effectively. See full prescribing information for verapamil hydrochloride extended-release capsules (PM). Verapamil Hydrochloride Extended-release Capsules (PM) (Controlled Onset) for Oral use Initial U.S. Approval: 19982
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4Bb3180408-a3c0-4e02-8535-dea390a522777
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BAmoxicillin and Clavulanate Potassium Tablets, USP1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BOrphenadrine Citrate Extended-release Tablets, 100 mg1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4Bd203780c-e770-435a-acff-0162e14836051
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19893
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BCARDIZEM ® CD (diltiazem HCl) Capsules1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BAmoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
EthylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BMAC TENDERTONE LIP BALM SPF 121
EthylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4B8a023942-01e8-4849-aa3c-1a640ffc7fd37
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BDrug Facts1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BDrug Facts1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BDrug Facts1
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BCiprofloxacin Extended-Release Tablets5
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BAmoxicillin and Clavulanate Potassium1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BBC09671
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4Ba6b1858a-e796-4cb0-8a4d-d5c521874e841
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4Be506b8dc-36b3-44f2-9fd6-316233efeb8b1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BPROPAFENONE HYDROCHLORIDE EXTENDED RELEASE CAPSULES1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4Bb8ca1d80-6ea9-4a3f-ab06-beedf845de8f1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BDrug Facts1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BDILTIAZEM HYDROCHLORIDE TABLETS, USP 60 mg and 120 mg1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4Befb195b9-b995-48f3-a4cb-b7e09d56350e2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BULTRAM ® ER (tramadol HCl) Extended-Release Tablets1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BWELLBUTRIN XL ® (bupropion hydrochloride extended-release tablets)1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BDEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES - CII2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use ACIPHEX safely and effectively. See full prescribing information for ACIPHEX. ACIPHEX (rabeprazole sodium) tablet, delayed release for oral use Initial U.S. Approval: 19992
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BMetadate CD ® (methylphenidate HCl, USP) Extended-Release Capsules CII1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BMETHYLDOPA TABLETS USP Rx only2
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BEquate Corn and Callus Remover3
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BDrug Facts1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BPRESCRIBING INFORMATION BuPROPion Hydrochloride Extended-Release Tablets (XL) Revised: August 2010 Rx only 174662-31
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BAMRIX ® (Cyclobenzaprine Hydrochloride Extended-Release Capsules)1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets for oral administration. Divalproex Sodium Extended-release Tablets Initial U.S. Approval: 20001
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BPotassium Chloride Extended-Release Capsules USP1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BIndomethacin Extended-Release Capsules USP2
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4Bf931d3af-c32a-4406-8799-9b097f41594b2
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4B6c826b0a-ac87-48cc-a780-9a4a2118e8a81
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BNIFEDIAC CC ® (nifedipine) Extended-release Tablets USP 90 mg1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BNifediac ® CC (Nifedipine) Extended-release Tablets, USP 30mg1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19891
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BAmoxicillin and Clavulanate Potassium Tablets, USP1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BWELLBUTRIN XL ® (bupropion hydrochloride extended-release tablets)1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BCARBAMAZEPINE TABLETS, USP1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4Bf38feadf-3fa4-430c-99ed-374023f8132c2
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BINDOMETHACIN EXTENDED RELEASE CAPSULES 75MG USP2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BIndomethacin Extended-Release Capsules USP1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BDEMECLOCYCLINE HYDROCHLORIDE Tablets, USP (Film Coated)2
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4B65261557-1a71-43a6-a549-d2a391e7dc321
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4B322513fd-6be0-4cd9-a0ea-7e4b5b5783362
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BCARBAMAZEPINE TABLETS USP, 200 mg/CARBAMAZEPINE CHEWABLE TABLETS USP, 100 mg 0109 0778 Rx only1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BENJUVIA® (synthetic conjugated estrogens, B) Tablets1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNorpace disopyramide phosphate capsules Norpace CR disopyramide phosphate extended-release capsules ® ®2
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNorpace disopyramide phosphate capsules Norpace CR disopyramide phosphate extended-release capsules ® ®2
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BCARBAMAZEPINE TABLETS USP, 200 mg/CARBAMAZEPINE CHEWABLE TABLETS USP, 100 mg 0109 0778 Rx only1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4B25994fad-388d-4f9c-950e-14b7f8073b8c1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4BRX Only1
ETHYLCELLULOSEINACTIVE INGREDIENT7Z8S9VYZ4B82f5292b-b113-4f10-9469-04386fa8e9d45
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BThese highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex sodium extended-release tablets for oral administration Initial U.S. Approval: 20002
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BCenestin ® (synthetic conjugated estrogens, A) Tablets1
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BWELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3682
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BAMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3628
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BKADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3612
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLIES DBA QUALITY CARE PRODUCTS LLC]3607
ethylcellulosesINACTIVE INGREDIENT7Z8S9VYZ4BDETROL LA (TOLTERODINE TARTRATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3599
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUTCS LLC]3575
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BAMRIX (CYCLOBENZAPRINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3486
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BKADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3413
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BBUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3311
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BPOTASSIUM CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS USA INC]1448
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BK-TAB (POTASSIUM CHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ABBVIE INC.]1445
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BCLARITHROMYCIN TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1003
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [BRYANT RANCH PREPACK]1001
ethylcelluloseINACTIVE INGREDIENT7Z8S9VYZ4BAMOXICILLIN/CLAVULANATE POTASSIUM TABLET [BRYANT RANCH PREPACK]1001
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNIFEDICAL XL (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BBUDEPRION (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BKADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BKADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BNIFEDIAC CC (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000